Margaret Isabelle Holcomb, CNM | |
2231 Burdett Ave Ste 160, Troy, NY 12180-2453 | |
(518) 326-1620 | |
Not Available |
Full Name | Margaret Isabelle Holcomb |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2231 Burdett Ave Ste 160, Troy, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467419531 | NPI | - | NPPES |
01914658 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 000653 (New York) | Secondary |
176B00000X | Midwife | 000653 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Margaret Isabelle Holcomb, CNM Po Box 14890, Albany, NY 12212-4890 Ph: (518) 525-5634 | Margaret Isabelle Holcomb, CNM 2231 Burdett Ave Ste 160, Troy, NY 12180-2453 Ph: (518) 326-1620 |
News Archive
Genetic counseling delivered over the telephone is as effective as face-to-face counseling, finds the largest randomized study to date comparing the two methods. The multi-center study, led by researchers at Georgetown Lombardi Comprehensive Cancer Center, was reported today in the Journal of Clinical Oncology.
Researchers have published a new study that suggests a signaling pathway called ROBO2 is a therapeutic target for kidney diseases, specifically kidney podocyte injury and glomerular diseases.
An online "spaced education" program designed to improve patient safety knowledge changes behaviors more effectively and is more engaging to medical and surgical interns than a slideshow plus quiz, report researchers.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product teduglutide (Revestive) as a once-daily treatment for adult patients with short bowel syndrome (SBS).
Culture, civic-mindedness and privacy concerns influence how willing people are to share personal location information to help stem the transmission of COVID-19 in their communities, a new study finds.
› Verified 5 days ago